New aromatic and aliphatic 3'-O-acyl-5-fluoro-2'-deoxyuridine derivatives were synthesized and evaluated as candidates for prodrugs against various cancer cell lines. As the most promising candidate for antimalignant therapeutics was found a dual-acting acyl derivative 7h, which apparently released not only the known anticancer nucleoside, 5-fluoro-2'-deoxyuridine (FdU), but also an additional active metabolite, acetylsalicylic acid, reinforcing thus therapeutic effect of FdU. Promising therapeutic indices showed also some aromatic dicarboxylic acids derivatives decorated with FdU esters (11 and 12).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejmech.2016.03.010 | DOI Listing |
Publication Analysis
Top Keywords
3'-o-aromatic acyl-5-fluoro-2'-deoxyuridine
4
acyl-5-fluoro-2'-deoxyuridine derivatives
4
derivatives potential
4
potential anticancer
4
anticancer agents
4
agents aromatic
4
aromatic aliphatic
4
aliphatic 3'-o-acyl-5-fluoro-2'-deoxyuridine
4
3'-o-acyl-5-fluoro-2'-deoxyuridine derivatives
4
derivatives synthesized
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!